Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies
暂无分享,去创建一个
M. Dougados | P. Tak | C. Peterfy | M. Genovese | P. Emery | E. Keystone | P. Tak | T. Kvien | G. Burmester | T. Shaw | D. Hagerty | M. Greenwald | T. Kvien | S. Cohen | S. Williams | M. Cravets | Stanley N. Cohen | Sarah Williams